420
Participants
Start Date
February 26, 2024
Primary Completion Date
July 8, 2026
Study Completion Date
July 8, 2026
Screening for heart failure
"• Anamnesis and Physical examination: Focus on signs of HF; will be performed by a trained employee.~• ECG: A standard 12-lead ECG will be recorded by a trained employee and will be interpreted by an experienced cardiologist.~• Echocardiography: A standard full echocardiogram will be acquired by a trained employee.~• Blood biomarkers: Venous blood samples will be taken and circulating levels of a broad range of markers related to obesity and/or heart failure will be determined. Also, an extra 10 mL blood sample will be drawn during the same venepuncture to be stored to determine additional biomarkers at a later stage.~• EQ-5D-5L questionnaire: EQ-5D-5L comprises five dimensions (mobility, self-care, usual activities, pain/discomfort and anxiety/depression), which are divided into five degrees of severity, ranging from 'no problems' to 'extreme problems'."
Franciscus Gasthuis & Vlietland, Rotterdam
Collaborators (4)
Erasmus Medical Center
OTHER
Star-shl
UNKNOWN
De Leefstijlkliniek
UNKNOWN
Leefstijl Centrum Rotterdam
UNKNOWN
Voedingsadvies Broer
UNKNOWN
Biotronik SE & Co. KG
INDUSTRY
Boehringer Ingelheim
INDUSTRY
Sanofi
INDUSTRY
Novo Nordisk A/S
INDUSTRY
Franciscus Gasthuis
OTHER